New research suggests clinicians should warn patients about the potential of cannabis to harm cardiovascular health. But how big a risk cannabis presents depends on the amount used and how much stock should be placed in observational studies.
The link between cannabinoids and cardiovascular disease, which used to be limited to evidence from preclinical studies, case reports, and case series, is now evident in epidemiological studies, researchers from Stanford reported in a recent paper in Nature Reviews Cardiology. Read more »
Comments are closed.